Clearly boardsters are disappointed because there’s no item on the agenda about the NGIO uplist. But..there was never any guarantee on Joe’s part that uplist would be discussed on the 2/5 call. We just assumed that to be the case. Friday’s apparent focus is covid vaccine development and covid treatments, with amplification on the various China deals. I say deals only because it’s unclear to me for which of several deals the $1m was paid. I’m not sure that it was a substitute for the $5m payment or simply a payment in another deal. But that I’m sure will be asked on Friday. I’m pleased to get ANY reliable good news at this point.